ledidi.com

What it is

Ledidi is an integrated research data platform for professional teams in life sciences and healthcare, covering clinical audits, registries, real-world evidence, post-market surveillance, and clinical trials. It is positioned not as a general-purpose BI tool, but as a shared workspace that brings together data capture, eCRF/form design, statistical analysis, visualization, and collaboration, helping hospitals, academic institutions, Medtech companies, pharmaceutical companies, and CROs move from Excel to more structured databases and analytics workflows.

Core capabilities

The platform provides drag-and-drop study design, variable definition, structured forms, Excel/CSV import, template reuse, status tracking, and data quality prompts. Its analytics layer includes built-in tools for frequencies, group comparisons, cross-tabulations, survival curves, correlation, and linear/logistic regression, and can generate real-time dashboards and exportable charts. The clinical trial module emphasizes no-code eCRF, randomization, monitoring and query management, audit trails, version control, electronic records, and electronic signatures, targeting GCP and FDA 21 CFR Part 11 use cases. The enterprise governance module supports project freezing, approval workflows, organizational reporting, and collaborator management.

Pricing and trial

Public materials indicate a 30-day trial is available. The cost calculator uses project-based and usage-based pricing: a one-time Go-live fee of €3,000, a monthly base fee of €100, €0.025 per patient/month, and €25.08 per site/month. Features such as Monitor, advanced randomization, ePROM/eCOA, eConsent, and eTMF add extra costs. Projects with more than 20,000 patients need to contact the company. Full package tiers, contract terms, and payment methods are not disclosed.

Security, integrations, and collaboration

Ledidi is built on AWS cloud infrastructure and uses Confidential Computing, encryption at rest and in transit, multi-factor authentication, logging, backup, and recovery mechanisms. The materials mention compliance capabilities related to ISO, GDPR, HIPAA, SOC II, as well as GCP, FDA 21 CFR Part 11, ICH GCP E6(R3), and ISPE GAMP 5. Its API supports import, export, update, and deletion, making it suitable for integration into existing data ecosystems. For collaboration, access can be controlled through roles and permissions, allowing researchers to analyze data without exposing sensitive raw data.

Pros, cons, and who it is for

Its strengths are a strong fit for medical research workflows, lower barriers to building EDC systems and performing statistical analysis, and relatively complete governance and audit capabilities. The downsides are that public pricing is still incomplete, details on feature add-ons are limited, and no self-hosting option is apparent. It is well suited to hospital departments, registry projects, multicenter studies, Medtech pre- and post-market evidence generation, and CRO collaboration projects. It is less suitable for general-purpose data analysis in ordinary enterprises.

Access from China

The available materials do not provide information on mainland China network access, RMB payment, local data residency, or MLPS-related compliance, so china_access is assessed as unknown. For Chinese teams handling sensitive medical data and cross-border compliance, it is important to first confirm data storage regions, contract terms, access stability, and local alternatives. Comparable options include REDCap, Castor EDC, Medidata Rave, Veeva Vault EDC, and domestic EDC/research data platforms.